{"Exaggerate": "The claim exaggerates by stating that researchers have found a \"simple cure for cancer,\" which is not supported by the expert's verdict. The expert states that preliminary research indicates potential promise for treating some forms of cancer, but it is not a proven cure.", "Understate": "The claim understates the effectiveness of glycolysis in fighting cancer, stating that it is \"less effective in curing cancer and more wasteful.\" The expert's verdict acknowledges that glycolysis has been a focus of drug manufacturers in fighting cancer.", "Lack enough support": "The claim lacks enough support for the statement that major pharmaceutical companies are not interested in the cure because it isn't patentable. The expert's verdict states that DCA is not being spurned by pharmaceutical companies because it is not patentable, indicating that there may be other reasons for their lack of interest.", "Problematic assumption": "The claim assumes that major pharmaceutical companies are not interested in the cure solely because it isn't patentable. The expert's verdict does not provide evidence to support this assumption and suggests that there may be other factors involved.", "Exist alternative explanation": "The claim does not consider alternative explanations for why major pharmaceutical companies are not investing in this research. The expert's verdict does not provide alternative explanations either, but it suggests that there may be other reasons beyond the lack of patentability."}